AIM: To investigate the presence of high-risk human papilloma virus (HPV) in esophageal squamous cell carcinomas (ESCCs) in a non-selected Mexican population. METHODS: Cases with a pathological diagnosis of squamous cell carcinoma of the esophagus were obtained from Department of Pathology files, at the National Cancer Institute in Mexico City during the period between 2000 and 2008. Slides from each case were reviewed and cases with sufficient neoplastic tissue were selected for molecular analysis. DNA was extracted from paraffin-embedded tissue samples for polymerase chain reaction analysis to detect HPV DNA sequences. Demographic and clinical data of each patient were retrieved from corresponding clinical records. RESULTS: HPV was detected in 15 (25%) of ESCCs. HPV-16 was the most frequently observed genotype, followed by HPV-18; HPV-59 was also detected in one case. Unfortunately, HPV genotype could not be established in three cases due to lack of material for direct sequencing, although universal primers detected the presence of HPV generic sequences. No low-risk HPV genotypes were found nor was HPV-16/18 co-infection. HPV presence in ESCC was not significantly associated with gender, age, alcohol consumption, smoking, anatomic location, or histologic grade. All patients belonged to low and very low socioeconomic strata, and were diagnosed at advanced disease stage. Male patients were most commonly affected and the male:female ratio in HPV-positive ESCC increased two-fold in comparison with HPV-negative cases (6.5:1 vs 3.1:1). CONCLUSION: High prevalence of high-risk HPV in ESCC in Mexico does not support the hypothesis that HPV-associated ESCC is more common in areas with higher ESCC incidence rates.
AIM: To investigate the presence of high-risk human papilloma virus (HPV) in esophageal squamous cell carcinomas (ESCCs) in a non-selected Mexican population. METHODS: Cases with a pathological diagnosis of squamous cell carcinoma of the esophagus were obtained from Department of Pathology files, at the National Cancer Institute in Mexico City during the period between 2000 and 2008. Slides from each case were reviewed and cases with sufficient neoplastic tissue were selected for molecular analysis. DNA was extracted from paraffin-embedded tissue samples for polymerase chain reaction analysis to detect HPV DNA sequences. Demographic and clinical data of each patient were retrieved from corresponding clinical records. RESULTS:HPV was detected in 15 (25%) of ESCCs. HPV-16 was the most frequently observed genotype, followed by HPV-18; HPV-59 was also detected in one case. Unfortunately, HPV genotype could not be established in three cases due to lack of material for direct sequencing, although universal primers detected the presence of HPV generic sequences. No low-risk HPV genotypes were found nor was HPV-16/18 co-infection. HPV presence in ESCC was not significantly associated with gender, age, alcohol consumption, smoking, anatomic location, or histologic grade. All patients belonged to low and very low socioeconomic strata, and were diagnosed at advanced disease stage. Male patients were most commonly affected and the male:female ratio in HPV-positive ESCC increased two-fold in comparison with HPV-negative cases (6.5:1 vs 3.1:1). CONCLUSION: High prevalence of high-risk HPV in ESCC in Mexico does not support the hypothesis that HPV-associated ESCC is more common in areas with higher ESCC incidence rates.
Authors: P Piña-Sánchez; D M Hernández-Hernández; R López-Romero; G Vázquez-Ortíz; C Pérez-Plasencia; M Lizano-Soberón; J L González-Sánchez; F Cruz-Talonia; M Salcedo Journal: Int J Gynecol Cancer Date: 2006 May-Jun Impact factor: 3.437
Authors: G M Clifford; S Gallus; R Herrero; N Muñoz; P J F Snijders; S Vaccarella; P T H Anh; C Ferreccio; N T Hieu; E Matos; M Molano; R Rajkumar; G Ronco; S de Sanjosé; H R Shin; S Sukvirach; J O Thomas; S Tunsakul; C J L M Meijer; S Franceschi Journal: Lancet Date: 2005 Sep 17-23 Impact factor: 79.321
Authors: Marjut A M Rintala; Seija E Grénman; Mirja H Puranen; Erika Isolauri; Ulla Ekblad; Pentti O Kero; Stina M Syrjänen Journal: J Clin Microbiol Date: 2005-01 Impact factor: 5.948
Authors: Guo-Fu Gao; Mark J Roth; Wen-Qiang Wei; Christian C Abnet; Feng Chen; Ning Lu; Fang-Hui Zhao; Xin-Qing Li; Guo-Qing Wang; Philip R Taylor; Qin-Jing Pan; Wen Chen; Sanford M Dawsey; You-Lin Qiao Journal: Int J Cancer Date: 2006-09-15 Impact factor: 7.396
Authors: Farin Kamangar; You-Lin Qiao; John T Schiller; Sanford M Dawsey; Thomas Fears; Xui-Di Sun; Christian C Abnet; Ping Zhao; Philip R Taylor; Steven D Mark Journal: Int J Cancer Date: 2006-08-01 Impact factor: 7.396
Authors: Y Yahyapour; M Shamsi-Shahrabadi; M Mahmoudi; A Motevallian; S Siadati; S Shefaii; J Shokri Shirvani; H R Mollaie; Seyed Hamid Reza Monavari; Hossein Keyvani Journal: Pathol Oncol Res Date: 2012-12-19 Impact factor: 3.201
Authors: Andrzej Dąbrowski; Wojciech Kwaśniewski; Tomasz Skoczylas; Wiesława Bednarek; Dorota Kuźma; Anna Goździcka-Józefiak Journal: World J Gastroenterol Date: 2012-10-28 Impact factor: 5.742